Found 21 matching trials
Study of Neoadjuvant Nivolumab or Placebo Plus Chemotherapy Followed by Surgery and Adjuvant Treatment in Subjects With Resectable ESCC
PHASE2Esophageal cancer, the 7th most common cancer globally, accounts for more t...
In-line Mechanical Insufflation-Exsufflation in the Management of Ventilated Patients
NACatheter suction (CS), the standard method for airway secretion management ...
Location
Multiple Locations
Intralesional Treatment With Interleukin-2 (Proleukin) in Soft Tissue Melanoma Metastases
PHASE2The intra-/perilesional application of interleukin-2 seems to be a safe and...
Location
Skin Cancer Program, Department of Dermatology, Liebermeisterstrasse 8
T-cell Based Immunotherapy for Head and Neck Cancer
PHASE1The aim of this study is to investigate the toxicity and immune response of...
Location
Department of Oncology, Copenhagen University Hospital, Herlev
The Comparison of Single and Multi-incision MIE for Esophageal Cancer
NAMinimally invasive esophagectomy (MIE) has been gradually adopted as a feas...
Adoptive Cell Therapy Across Cancer Diagnoses
PHASE1This study will perform tumor-infiltrating lymphocyte (TIL)-based adoptive ...
Location
Center for Cancer immune Therapy (CCIT), Dept. of Hematology and dept. of Oncology
Comprehensive Toileting Program
PHASE4The current study aims to monitor fecal continence after autistic youth com...
Location
Marcus Autism Center
The Optimal Antibiotic Treatment Duration for Community-acquired Pneumonia in Adults Diagnosed in General Practice in Denmark (CAP-D)
PHASE4The aim of this randomised controlled trial is to identify the optimal trea...
Location
The Research Unit for General Practice Aalborg
Traditional Three Incisions vs Minimally Invasive Thoracol-laparoscopic Esophagectomy for Esophageal Cancer
PHASE3This study is a multi-center, randomized, and open-label trial to compare t...
Location
Cancer Hospital of Chinese Academy of Medical Science
T-cell Based Immunotherapy for of Melanoma
PHASE1The aim of this study is to investigate the toxicity and clinical response ...
Location
Department of Oncology, Copenhagen University Hospital, Herlev